China's powerful state planner said on Friday the government has never required Chinese technology companies to reject foreign investment, responding to a media question about whether Beijing plans to ask Chinese firms to refuse investment from U.S. capital.
Chinese stocks, ETFs and related themes posted some of the biggest rallies in months.
China's factory-gate inflation gathered momentum in April, fueled by geopolitical tensions in the Middle East that kept energy costs elevated and cemented the end of a nearly four-year deflationary cycle.
The official purchasing managers' index reading of 50.3, was higher than the the 50.1 expected by Reuters-polled economists.
Asian markets began on Wednesday on an uneven footing as investors weighed multiple factors. The sentiment appeared cautious following a technology-led selloff in the United States, fresh concerns about the sustainability of AI spending, and lingering tension surrounding the Iran conflict.
The sectors that could be winners may be those that are closest to the safety net, like healthcare, insurance and eldercare.
Farther Finance Advisors LLC grew its holdings in shares of Xtrackers Harvest CSI 300 China A-Shares ETF (NYSEARCA:ASHR) by 4,802.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,486 shares of the exchange traded fund's stock after
The Xtrackers Harvest CSI 300 China A-Shares ETF delivered a strong 22.62% total return over the past year. ASHR's performance was not primarily driven by multiple expansion but by double-digit earnings growth among its holdings. Despite the negative headlines around the country, Chinese companies are advancing rapidly and are taking market share in almost every sector.
Beijing tamped down its GDP growth target this year to a range of 4.5% to 5%, the least ambitious goal on record going back to the early 1990s.
China's ongoing negative PPI supports a deflationary trend, benefiting global markets and providing a constructive backdrop for Xtrackers Harvest CSI 300 China A-Shares ETF. ASHR remains attractively valued with a low P/E ratio, solid long-term EPS growth, and a fair PEG, supporting my continued buy rating. Technical momentum is strong, with shares testing key resistance and a potential upside target of $35 if the uptrend persists.
DWS has operated in the ETF space via its Xtrackers family of funds in the US for nearly 20 years. It has flown under the radar compared to the largest ETF issuers.
Not even a quarter into 2025 and we've been on a roller coaster of economic and market events. It's the perfect time for the Exchange conference, where advisors, issuers, and other market experts can come together and share ideas.